[Pharmacology of cannabidiol: Red flags, consequences and risks in humans].
The´rapie 2022 Joëlle Micallef, Anne Batisse, Bruno Revol
Scientific knowledge about cannabidiol (CBD) demonstrates that CBD is a substance that is not pharmacologically inert. If it does not act efficiently on cannabinoid receptors (those where tetrahydrocannabidol [THC] is fixed), it acts on brain receptors, especially on dopamine and serotonin receptors, making it a psychoactive product in its own right. Its consumption can thus have psychoactive...
DOI: 10.1016/j.therap.2022.02.001 (opens in new tab)
Full text (opens in new tab)
Cannabidiol
Addictovigilance
Drug interaction
Effets snc
+4